Efferocytosis inhibition enhances the anticancer immune response of hybrid cell membrane-coated nanoparticles.
The immunogenic cell death (ICD) of tumor cells generates abundant damage-associated molecular patterns (DAMPs) to induce efficient anti-tumor immune responses. However, dysregulated efferocytosis causes rapid clearance of DAMPs, thereby impeding immunotherapy progression. It has been revealed that the externalization...